Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03656276 · ClinicalTrials.gov registry record
The "ToPIC" Study = Tool to Improve Participation In Clinical Trials
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 35
- Enrollment target
NCT03656276: Completed study, sponsored by University of Wisconsin, Madison.
NCT03656276 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03656276 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to pilot the "ToPIC" tool, a communication tool to facilitate clinical trial decision making conversations between oncologists and patients.
Primary Outcome
Number of patients that consent to a therapeutic trial in the wait-list control vs. the trained oncologist groups. Per protocol, there is no timeframe within which patients need to consent. Due to the nature of oncology care, some patients are presented with the trial months before they are eligible, and the team follows up to see if they choose to consent if/when they are eligible.
Interventions
- BEHAVIORAL Tool to improve Participation In Clinical Trials (ToPIC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-03-10 |
| Est. Completion | 2018-12-31 |
What the finished NCT03656276 record still lists
NCT03656276 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Tool to improve Participation In Clinical Trials (ToPIC) is the first listed.
NCT03656276 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03656276 about?
NCT03656276 is a clinical study titled "The "ToPIC" Study = Tool to Improve Participation In Clinical Trials". The purpose of this study is to pilot the "ToPIC" tool, a communication tool to facilitate clinical trial decision making conversations between oncologists and patients.
What is the current status of trial NCT03656276?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2017-03-10. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03656276?
The interventions under investigation include: Tool to improve Participation In Clinical Trials (ToPIC) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03656276?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI